Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bloomfield

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Cardiovascular Drugs and Therapy|June 29, 2017
Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart FailureLicette C Y Liu, Mattia A E Valente, Douwe Postmus, et al.
European Journal of Heart Failure|October 30, 2015
Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcomeJohanna E Emmens, Jozine M Ter Maaten, Yuya Matsue, et al.
Heart (British Cardiac Society)|September 24, 2016
Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failureYuya Matsue, Peter van der Meer, Kevin Damman, et al.
The American Journal of Cardiology|November 9, 2016
Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials)Jasper Tromp, Jozine M Ter Maaten, Kevin Damman, et al.
Clinical Pharmacology and Therapeutics|June 27, 2008
Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjectsR Krishna, A J Bergman, B Jin, et al.
International Journal of Cardiology|November 17, 2015
MicroRNAs relate to early worsening of renal function in patients with acute heart failureNoemi Bruno, Jozine M ter Maaten, Ekaterina S Ovchinnikova, et al.
European Journal of Heart Failure|September 9, 2015
Signature of circulating microRNAs in patients with acute heart failureEkaterina S Ovchinnikova, Daniela Schmitter, Eline L Vegter, et al.
European Journal of Heart Failure|March 28, 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessmentMartin R Cowie, Gerasimos S Filippatos, Maria de Los Angeles Alonso Garcia, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
Physics in Medicine and Biology|November 24, 2004
GATE: a simulation toolkit for PET and SPECTS Jan, G Santin, D Strul, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Cardiovascular Drugs and Therapy|June 29, 2017
Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart FailureLicette C Y Liu, Mattia A E Valente, Douwe Postmus, et al.
European Journal of Heart Failure|October 30, 2015
Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcomeJohanna E Emmens, Jozine M Ter Maaten, Yuya Matsue, et al.
Heart (British Cardiac Society)|September 24, 2016
Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failureYuya Matsue, Peter van der Meer, Kevin Damman, et al.
The American Journal of Cardiology|November 9, 2016
Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials)Jasper Tromp, Jozine M Ter Maaten, Kevin Damman, et al.
Clinical Pharmacology and Therapeutics|June 27, 2008
Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjectsR Krishna, A J Bergman, B Jin, et al.
International Journal of Cardiology|November 17, 2015
MicroRNAs relate to early worsening of renal function in patients with acute heart failureNoemi Bruno, Jozine M ter Maaten, Ekaterina S Ovchinnikova, et al.
European Journal of Heart Failure|September 9, 2015
Signature of circulating microRNAs in patients with acute heart failureEkaterina S Ovchinnikova, Daniela Schmitter, Eline L Vegter, et al.
European Journal of Heart Failure|March 28, 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessmentMartin R Cowie, Gerasimos S Filippatos, Maria de Los Angeles Alonso Garcia, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
Physics in Medicine and Biology|November 24, 2004
GATE: a simulation toolkit for PET and SPECTS Jan, G Santin, D Strul, et al.
Pageof 19